dactinomycin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denk, U; Egle, A; Greil, R; Hamacher, F; Hofbauer, JP; Kenner, L; Kocher, T; Melchardt, T; Merkel, O; Scheideler, M; Schlederer, M; Sifft, E; Steurer, M; Wacht, N | 1 |
| Chubb, S; Ford, R; Hittelman, WN; Meyn, RE; Plunkett, W; Robertson, LE; Story, M | 1 |
| Al-Katib, A; Gabrilove, JL; König, A; Lynen, S; Menzel, T; Raveche, E; Rosén, A; Wrazel, L | 1 |
| Aguilar-Santelises, M; Celsing, F; Diaz, T; Jondal, M; Olsson, A; Osorio, LM; Osterborg, A | 1 |
| Brownstein, BH; Golomb, HM; Samuels, BL; Vokes, EE | 1 |
5 other study(ies) available for dactinomycin and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Dactinomycin; Female; Flow Cytometry; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Inbred C57BL; Mice, SCID; Mice, Transgenic; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Survival Rate; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vidarabine | 2012 |
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine.
Topics: Adenosine Triphosphate; Apoptosis; Cladribine; Cycloheximide; Dactinomycin; DNA, Neoplasm; Egtazic Acid; Guanosine Triphosphate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Microscopy, Electron; Puromycin; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Uridine Triphosphate; Vidarabine | 1993 |
Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
Topics: Apoptosis; B-Lymphocytes; Cell Line, Transformed; Dactinomycin; DNA Fragmentation; Fibroblast Growth Factor 2; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Vidarabine | 1997 |
Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
Topics: Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Dactinomycin; Drug Synergism; Female; GPI-Linked Proteins; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Membrane Glycoproteins; Middle Aged; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 10c; RNA, Messenger; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2001 |
Heat shock proteins in normal and leukemic blood cells.
Topics: Dactinomycin; Electrophoresis, Polyacrylamide Gel; Heat-Shock Proteins; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Lymphocytes; Recombinant Proteins | 1989 |